Revenue Breakdown
Composition ()
No data
Revenue Streams
Nexalin Technology Inc (NXL) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Equipment , accounting for 74.4% of total sales, equivalent to $52.53K. Other significant revenue streams include Licensing Fee and Other. Understanding this composition is critical for investors evaluating how NXL navigates market cycles within the Advanced Medical Equipment & Technology industry.
Profitability & Margins
Evaluating the bottom line, Nexalin Technology Inc maintains a gross margin of 78.25%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -12924.30%, while the net margin is -12542.35%. These profitability ratios, combined with a Return on Equity (ROE) of -178.46%, provide a clear picture of how effectively NXL converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, NXL competes directly with industry leaders such as HSCS and CLGN. With a market capitalization of $8.23M, it holds a significant position in the sector. When comparing efficiency, NXL's gross margin of 78.25% stands against HSCS's 58.33% and CLGN's -249.35%. Such benchmarking helps identify whether Nexalin Technology Inc is trading at a premium or discount relative to its financial performance.
